New Data Reconfirms Long-term Safety Profile of the Philips Stellarex Low-dose Drug-Coated Balloon

Amsterdam, the Netherlands, June 26 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the four-year results from the ILLUMENATE European Randomized Controlled Trial (EU RCT). The Stellarex DCB cohort demonstrated similar all-cause mortality compared with the control arm through four years. This analysis included missing data found post [...]